Header Logo

Connection

MARIETTA DEGUZMAN to Rituximab

Back to Details
This is a "connection" page, showing publications MARIETTA DEGUZMAN has written about Rituximab.
MARIETTA DEGUZMAN
Connection Strength
0.542
Rituximab
  1. Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disorders. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.542
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.